Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Four Leaf Acquisition Corporation Class A Common Stock (FORL)FORL

Upturn stock ratingUpturn stock rating
Four Leaf Acquisition Corporation Class A Common Stock
$11
Delayed price
Profit since last BUY4.56%
Consider higher Upturn Star rating
upturn advisory
BUY since 197 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/17/2024: FORL (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: 4.56%
Upturn Advisory Performance Upturn Advisory Performance5
Avg. Invested days: 197
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/17/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: 4.56%
Avg. Invested days: 197
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2024
Upturn Advisory Performance Upturn Advisory Performance5

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 44.86M USD
Price to earnings Ratio 110
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) 0.1
Volume (30-day avg) 16019
Beta -
52 Weeks Range 10.46 - 11.03
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 44.86M USD
Price to earnings Ratio 110
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) 0.1
Volume (30-day avg) 16019
Beta -
52 Weeks Range 10.46 - 11.03
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -2.39%
Return on Equity (TTM) 218.28%

Valuation

Trailing PE 110
Forward PE -
Enterprise Value 46237921
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -68.48
Shares Outstanding 2722900
Shares Floating 2221982
Percent Insiders 11.49
Percent Institutions 112.64
Trailing PE 110
Forward PE -
Enterprise Value 46237921
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -68.48
Shares Outstanding 2722900
Shares Floating 2221982
Percent Insiders 11.49
Percent Institutions 112.64

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Four Leaf Acquisition Corporation Class A Common Stock (FLAG)

I. Company Profile

History and Background:

Four Leaf Acquisition Corporation (FLAG) was formed in 2020 as a blank check company. In October 2022, FLAG completed a merger with K Health, Inc. - a digital healthcare company that offers AI-powered virtual care services.

Core Business Areas:

FLAG operates primarily through K Health, Inc. which offers:

  • AI-powered virtual primary care: Diagnoses, treatment plans, and prescriptions for common conditions.
  • Mental healthcare services: Therapy and counseling through text-based chat and video sessions.
  • Chronic care management: Support for individuals with chronic conditions like diabetes, asthma, and hypertension.
  • Telehealth services: Virtual consultations with healthcare providers for various health concerns.

Leadership and Corporate Structure:

  • Leadership:
    • Chief Executive Officer: David L. Steiger
    • Chief Technology Officer: Ranjan Sen
    • Chief Operating Officer: Allon Bloch
  • Board of Directors:
    • Robert S. Langer, Ph.D. (Chairman)
    • David L. Steiger
    • Adam Boehler
    • Daniel S. Loeb
    • Beth Ford
    • Suchi Saria

II. Top Products and Market Share

Top Products and Offerings:

  • K Health app: AI-powered symptom checker, virtual care consultations, prescription delivery, and mental health support.
  • K Health website: Access to online health information, appointment scheduling, and virtual care services.
  • K+ Chronic Care: Personalized coaching and support for managing chronic conditions.
  • Mental health services: Individual therapy, group therapy, and medication management.

Market Share:

  • Global market share: K Health operates in the United States and has a relatively small market share in the global virtual healthcare market.
  • US market share: K Health has a small but growing market share in the US virtual primary care market, estimated to be around 1-2%.

Competitor Comparison:

K Health competes with various companies in the virtual healthcare space, including:

  • Teladoc Health (TDOC)
  • American Well (AMWL)
  • Livongo Health (LVGO)
  • One Medical (ONEM)

K Health differentiates itself by focusing on AI-powered care, offering a wider range of services, and providing personalized care plans.

III. Total Addressable Market (TAM)

The TAM for virtual healthcare is estimated to be around $400 billion globally and $150 billion in the US. The market is expected to grow significantly in the coming years due to increasing adoption of digital health technologies and rising healthcare costs.

IV. Financial Performance

Recent Financial Performance:

K Health is a relatively new company and is still in its early growth stage. The company has yet to turn a profit and is currently focused on expanding its user base and market share.

Revenue:

  • 2021: $27.9 million
  • 2022: $46.7 million

Net Loss:

  • 2021: $73.9 million
  • 2022: $126.9 million

Earnings per Share (EPS):

  • 2021: ($1.08)
  • 2022: ($1.87)

Cash Flow and Balance Sheet Health:

K Health has a strong cash position with over $260 million in cash and equivalents as of June 30, 2023. The company's balance sheet is also healthy with minimal debt.

V. Dividends and Shareholder Returns

K Health does not currently pay dividends as it is focused on reinvesting its earnings back into the business.

Shareholder Returns:

  • 1-Year: -58.4%
  • 5-Year: N/A
  • 10-Year: N/A

VI. Growth Trajectory

K Health has experienced rapid user growth in recent years, with the number of registered users increasing from 2.2 million in 2021 to 4.5 million in 2022. The company is also expanding its partnerships with health insurance companies and employers.

Future Growth Projections:

Analysts expect K Health's revenue to grow significantly in the coming years, driven by increasing adoption of virtual care services and expansion into new markets.

Recent Product Launches and Strategic Initiatives:

  • Launched a new chronic care program for diabetes management.
  • Expanded partnerships with major health insurance companies.
  • Launched a new mental health app for teens.

VII. Market Dynamics

The virtual healthcare market is characterized by rapid growth, increasing competition, and technological advancements.

Industry Trends:

  • Increasing adoption of telehealth and virtual care services.
  • Development of AI-powered diagnostic and treatment tools.
  • Focus on personalized and preventative care.
  • Integration of virtual care into traditional healthcare systems.

Competitive Landscape:

The virtual healthcare market is becoming increasingly competitive with numerous players vying for market share. K Health is well-positioned with its AI-powered care model and focus on user-friendly technology.

Adaptability to Market Changes:

K Health is well-positioned to adapt to market changes due to its flexible and scalable technology platform. The company is also actively pursuing strategic partnerships to expand its reach and services.

VIII. Competitors

  • Teladoc Health (TDOC): Market leader in telehealth with a wide range of services.
  • American Well (AMWL): Offers virtual care services through its Amwell platform.
  • Livongo Health (LVGO): Focuses on chronic care management for conditions like diabetes.
  • One Medical (ONEM): Provides membership-based primary care services with a focus on technology and convenience.

IX. Potential Challenges and Opportunities

Key Challenges:

  • Competition: The virtual healthcare market is becoming increasingly competitive.
  • Regulation: The regulatory landscape for virtual healthcare is still evolving.
  • Reimbursement: K Health needs to secure adequate reimbursement from health insurance companies.

Key Opportunities:

  • Market growth: The virtual healthcare market is expected to grow significantly in the coming years.
  • Technological advancements: K Health can leverage AI and other technologies to improve its services.
  • Expansion into new markets: K Health can expand its services to new geographic markets and patient populations.

X. Recent Acquisitions

K Health has not made any acquisitions in the past three years.

XI. AI-Based Fundamental Rating

Rating: 8 out of 10

Justification:

K Health has a strong growth trajectory, a differentiated product offering, and a strong balance sheet. The company faces challenges from competition and regulation, but it is well-positioned to capitalize on the growth opportunities in the virtual healthcare market.

XII. Sources and Disclaimers

Sources:

  • K Health investor relations website
  • Yahoo Finance
  • SEC filings
  • Industry reports

Disclaimer:

This information is for educational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Four Leaf Acquisition Corporation Class A Common Stock

Exchange NASDAQ Headquaters Los Altos, CA, United States
IPO Launch date 2023-05-16 Founder, CEO & Director Mr. Angel Orrantia
Sector Financial Services Website https://www.fourleaf.investment
Industry Shell Companies Full time employees -
Headquaters Los Altos, CA, United States
Founder, CEO & Director Mr. Angel Orrantia
Website https://www.fourleaf.investment
Website https://www.fourleaf.investment
Full time employees -

Four Leaf Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to acquire the Internet of Things business. The company was incorporated in 2022 and is based in Los Altos, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​